Skip to main content

Sohn Catherine A.

In the past year, 1 open-market purchase filing worth $2.12K and 1 sale filing worth $1.15M.

Current role at each company

Show 1 more company

Open-market trades in the past year

Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.

Bought
$2.12K
1 filing
Sold
$1.15M
1 filing
Net
−$1.15M
Bought minus sold
Companies
2
With open-market trades

Trades

Every Form 4 that lists Sohn Catherine A. as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.

MAZE Maze Therapeutics, Inc.

Director1 trade

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Jan 8, 2026 (view filing)Jan 6-72 daysSohn Catherine A.DirectorSSale−29.4K$39.07−$1.15M−100.0%0 after2 lots

ALT Altimmune, Inc.

Director2 trades

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Jan 5, 2026 (view filing)Jan 5Same daySohn Catherine A.DirectorPPurchaseCommon Stock, par value $0.0001+500$4.24+$2.12K+50.0%1.50K after
Mar 18, 2025 (view filing)Mar 171 daySohn Catherine A.DirectorPPurchaseCommon Stock, par value $0.0001+1.00K$5.78+$5.78KNew position1.00K after

JAZZ Jazz Pharmaceuticals plc

Director3 trades

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Aug 15, 2023 (view filing)Aug 141 daySohn Catherine A.DirectorSSale−1.24K$138.16−$171.5K−7.7%14.9K after
Aug 9, 2022 (view filing)Aug 81 daySohn Catherine A.DirectorSSale−1.09K$152.32−$165.9K−7.7%13.0K after
Aug 10, 2021 (view filing)Aug 64 daysSohn Catherine A.DirectorSSale−1.31K$147.96−$193.2K−10.1%11.6K after